In This Section      
 

Search Results

A total of 2 matching records were found.

J17143
J17143 - A Phase 1 Open-label Dose Escalation and Dose Expansion Study of CGX1321 in Subjects with Advanced Solid Tumors and Phase 1b Study of CGX1321 in Combination with Pembrolizumab in Subjects with Advanced Gastrointestinal Tumors

Sites: Johns Hopkins Kimmel Cancer Center in Baltimore

J1989
J1989 - A Phase I, First-In-Human, Multicenter, Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Sites: Johns Hopkins Kimmel Cancer Center in Baltimore